Skip to main content
Erschienen in: Digestive Diseases and Sciences 9/2017

09.03.2017 | Original Article

Is There a Link Between H. Pylori and the Epidemiology of Crohn’s Disease?

verfasst von: Ayesha Shah, Nicholas J. Talley, Marjorie Walker, Natasha Koloski, Mark Morrison, Daniel Burger, Jane M. Andrews, Michael McGuckin, Mike Jones, Gerald Holtmann

Erschienen in: Digestive Diseases and Sciences | Ausgabe 9/2017

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Case control studies suggest an inverse association between Helicobacter pylori (H. pylori) and Crohn’s disease (CD). It is possible this could be accounted for by confounders such as antibiotic therapy. Analyzing the geographic distribution of H. pylori and the links with the incidence and prevalence of CD would be an alternative approach to circumvent these confounders.

Methods

The literature was searched for studies published between 1990 and 2016 that reported incidence or prevalence data for CD in random population samples in developed countries (GDP per capita >20,000 USD/year). Corresponding prevalence studies for H. pylori in these same regions were then sought matched to the same time period (±6 years). The association between the incidence and prevalence of CD and H. pylori prevalence rates were assessed before and after adjusting for GDP and life expectancy.

Results

A total of 19 CD prevalence and 22 CD incidence studies from 10 European countries, Japan, USA, and Australia with date-matched H. pylori prevalence data were identified. The mean H. pylori prevalence rate was 43.4% (range 15.5–85%), and the mean rates for incidence and prevalence for CD were 6.9 and 91.0/100,000 respectively. The incidence (r = −0.469, p < 0.03) and prevalence (r = −0.527, p = 0.02) of CD was inversely and significantly associated with prevalence of H. pylori infection.

Conclusions

Our data demonstrate a significant inverse association between geographic distribution of H. pylori and CD. Thus, it is highly unlikely that the findings of previous case control studies were simply due to confounding factors such as concomitant antibiotic use in CD patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Koloski NA, Bret L, Radford-Smith G. Hygiene hypothesis in inflammatory bowel disease: a critical review of the literature. World J Gastroenterol: WJG. 2008;14:165–173.PubMedPubMedCentralCrossRef Koloski NA, Bret L, Radford-Smith G. Hygiene hypothesis in inflammatory bowel disease: a critical review of the literature. World J Gastroenterol: WJG. 2008;14:165–173.PubMedPubMedCentralCrossRef
2.
Zurück zum Zitat Amre D. Gene-environment interactions in the etiopathogenesis of inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2005;40:S39.PubMedCrossRef Amre D. Gene-environment interactions in the etiopathogenesis of inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2005;40:S39.PubMedCrossRef
3.
Zurück zum Zitat Uniken Venema WT, Voskuil MD, Dijkstra G, Weersma RK, Festen EA. The genetic background of inflammatory bowel disease: from correlation to causality. J Pathol. 2017;241:146–158.PubMedCrossRef Uniken Venema WT, Voskuil MD, Dijkstra G, Weersma RK, Festen EA. The genetic background of inflammatory bowel disease: from correlation to causality. J Pathol. 2017;241:146–158.PubMedCrossRef
4.
Zurück zum Zitat Loftus CG, Loftus EV Jr., Harmsen WS, et al. Update on the incidence and prevalence of Crohn’s disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000. Inflamm Bowel Dis. 2007;13:254–261.PubMedCrossRef Loftus CG, Loftus EV Jr., Harmsen WS, et al. Update on the incidence and prevalence of Crohn’s disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000. Inflamm Bowel Dis. 2007;13:254–261.PubMedCrossRef
5.
Zurück zum Zitat Prideaux L, Kamm MA, De Cruz PP, Chan FK, Ng SC. Inflammatory bowel disease in Asia: a systematic review. J Gastroenterol Hepatol. 2012;27:1266–1280.PubMedCrossRef Prideaux L, Kamm MA, De Cruz PP, Chan FK, Ng SC. Inflammatory bowel disease in Asia: a systematic review. J Gastroenterol Hepatol. 2012;27:1266–1280.PubMedCrossRef
6.
Zurück zum Zitat Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119–124.PubMedPubMedCentralCrossRef Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119–124.PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Amre DK, Lambrette P, Law L, et al. Investigating the hygiene hypothesis as a risk factor in pediatric onset Crohn’s disease: a case-control study. Am J Gastroenterol. 2006;101:1005–1011.PubMedCrossRef Amre DK, Lambrette P, Law L, et al. Investigating the hygiene hypothesis as a risk factor in pediatric onset Crohn’s disease: a case-control study. Am J Gastroenterol. 2006;101:1005–1011.PubMedCrossRef
8.
Zurück zum Zitat Bernstein CN, Rawsthorne P, Cheang M, Blanchard JF. A population-based case control study of potential risk factors for IBD. Am J Gastroenterol. 2006;101:993–1002.PubMedCrossRef Bernstein CN, Rawsthorne P, Cheang M, Blanchard JF. A population-based case control study of potential risk factors for IBD. Am J Gastroenterol. 2006;101:993–1002.PubMedCrossRef
9.
Zurück zum Zitat Lashner BA, Loftus EV Jr. True or false? The hygiene hypothesis for Crohn’s disease. Am J Gastroenterol. 2006;101:1003–1004.PubMedCrossRef Lashner BA, Loftus EV Jr. True or false? The hygiene hypothesis for Crohn’s disease. Am J Gastroenterol. 2006;101:1003–1004.PubMedCrossRef
10.
Zurück zum Zitat Kao JY, Zhang M, Miller MJ, et al. Helicobacter pylori immune escape is mediated by dendritic cell—induced Treg skewing and Th17 suppression in mice. Gastroenterology. 2010;138:1046–1054.PubMedCrossRef Kao JY, Zhang M, Miller MJ, et al. Helicobacter pylori immune escape is mediated by dendritic cell—induced Treg skewing and Th17 suppression in mice. Gastroenterology. 2010;138:1046–1054.PubMedCrossRef
11.
Zurück zum Zitat Sonnenberg A, Genta RM. Low prevalence of Helicobacter pylori infection among patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2012;35:469–476.PubMedCrossRef Sonnenberg A, Genta RM. Low prevalence of Helicobacter pylori infection among patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2012;35:469–476.PubMedCrossRef
12.
Zurück zum Zitat Deeks JJ, Dinnes J, D’Amico R, et al. Evaluating non-randomised intervention studies. Health Technol Assess. 2003;7:iii–x. (1–173).PubMedCrossRef Deeks JJ, Dinnes J, D’Amico R, et al. Evaluating non-randomised intervention studies. Health Technol Assess. 2003;7:iii–x. (1–173).PubMedCrossRef
13.
Zurück zum Zitat Levesque R. SPSS Programming and Data Management: A Guide for SPSS and SAS Users. 4th ed. Chicago, Ill: SPSS Inc.; 2007. PDF ISBN 1-56827-390-8. Levesque R. SPSS Programming and Data Management: A Guide for SPSS and SAS Users. 4th ed. Chicago, Ill: SPSS Inc.; 2007. PDF ISBN 1-56827-390-8.
14.
Zurück zum Zitat Rokkas T, Gisbert JP, Niv Y, O’Morain C. The association between Helicobacter pylori infection and inflammatory bowel disease based on meta-analysis. United Eur Gastroenterol J. 2015;3:539–550.CrossRef Rokkas T, Gisbert JP, Niv Y, O’Morain C. The association between Helicobacter pylori infection and inflammatory bowel disease based on meta-analysis. United Eur Gastroenterol J. 2015;3:539–550.CrossRef
15.
Zurück zum Zitat Wu X-W, Ji H-Z, Yang M-F, Wu L, Wang F-Y. Helicobacter pylori infection and inflammatory bowel disease in Asians: a meta-analysis. World J Gastroenterol: WJG. 2015;21:4750–4756.PubMedPubMedCentral Wu X-W, Ji H-Z, Yang M-F, Wu L, Wang F-Y. Helicobacter pylori infection and inflammatory bowel disease in Asians: a meta-analysis. World J Gastroenterol: WJG. 2015;21:4750–4756.PubMedPubMedCentral
16.
Zurück zum Zitat Castaño-Rodriguez N, Kaakoush NO, Lee WS, Mitchell HM. Dual role of Helicobacter and Campylobacter species in IBD: a systematic review and meta-analysis. Gut. 2017;66:235–249.PubMedCrossRef Castaño-Rodriguez N, Kaakoush NO, Lee WS, Mitchell HM. Dual role of Helicobacter and Campylobacter species in IBD: a systematic review and meta-analysis. Gut. 2017;66:235–249.PubMedCrossRef
17.
Zurück zum Zitat Luther J, Dave M, Higgins PD, Kao JY. Association between Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature. Inflamm Bowel Dis. 2010;16:1077–1084.PubMedPubMedCentralCrossRef Luther J, Dave M, Higgins PD, Kao JY. Association between Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature. Inflamm Bowel Dis. 2010;16:1077–1084.PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Gong YH, Sun LP, Jin SG, Yuan Y. Comparative study of serology and histology based detection of Helicobacter pylori infections: a large population-based study of 7,241 subjects from China. Eur J Clin Microbiol Infect Dis. 2010;29:907–911.PubMedCrossRef Gong YH, Sun LP, Jin SG, Yuan Y. Comparative study of serology and histology based detection of Helicobacter pylori infections: a large population-based study of 7,241 subjects from China. Eur J Clin Microbiol Infect Dis. 2010;29:907–911.PubMedCrossRef
19.
Zurück zum Zitat Guarner J, Kalach N, Elitsur Y, Koletzko S. 2010 Helicobacter pylori diagnostic tests in children: review of the literature from 1999 to 2009. Eur J Pediatr. 2010;169:15–25.PubMedCrossRef Guarner J, Kalach N, Elitsur Y, Koletzko S. 2010 Helicobacter pylori diagnostic tests in children: review of the literature from 1999 to 2009. Eur J Pediatr. 2010;169:15–25.PubMedCrossRef
20.
21.
Zurück zum Zitat Nakajima S, Nishiyama Y, Yamaoka M, Yasuoka T, Cho E. Changes in the prevalence of Helicobacter pylori infection and gastrointestinal diseases in the past 17 years. J Gastroenterol Hepatol. 2010;25:S99–S110.PubMedCrossRef Nakajima S, Nishiyama Y, Yamaoka M, Yasuoka T, Cho E. Changes in the prevalence of Helicobacter pylori infection and gastrointestinal diseases in the past 17 years. J Gastroenterol Hepatol. 2010;25:S99–S110.PubMedCrossRef
22.
Zurück zum Zitat Jess T, Riis L, Vind I, et al. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm Bowel Dis. 2007;13:481–489.PubMedCrossRef Jess T, Riis L, Vind I, et al. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm Bowel Dis. 2007;13:481–489.PubMedCrossRef
23.
Zurück zum Zitat Sewell JL, Yee HF Jr., Inadomi JM. Hospitalizations are increasing among minority patients with Crohn’s disease and ulcerative colitis. Inflamm Bowel Dis. 2010;16:204–207.PubMedCrossRef Sewell JL, Yee HF Jr., Inadomi JM. Hospitalizations are increasing among minority patients with Crohn’s disease and ulcerative colitis. Inflamm Bowel Dis. 2010;16:204–207.PubMedCrossRef
24.
Zurück zum Zitat Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46e42–54e42. (quiz e30).CrossRef Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46e42–54e42. (quiz e30).CrossRef
25.
Zurück zum Zitat Gearry RB, Richardson AK, Frampton CM, Dodgshun AJ, Barclay ML. Population-based cases control study of inflammatory bowel disease risk factors. J Gastroenterol Hepatol. 2010;25:325–333.PubMedCrossRef Gearry RB, Richardson AK, Frampton CM, Dodgshun AJ, Barclay ML. Population-based cases control study of inflammatory bowel disease risk factors. J Gastroenterol Hepatol. 2010;25:325–333.PubMedCrossRef
26.
Zurück zum Zitat Wilson J, Hair C, Knight R, et al. High incidence of inflammatory bowel disease in Australia: a prospective population-based Australian incidence study. Inflamm Bowel Dis. 2010;16:1550–1556.PubMedCrossRef Wilson J, Hair C, Knight R, et al. High incidence of inflammatory bowel disease in Australia: a prospective population-based Australian incidence study. Inflamm Bowel Dis. 2010;16:1550–1556.PubMedCrossRef
27.
Zurück zum Zitat Thia KT, Loftus EV Jr., Sandborn WJ, Yang SK. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol. 2008;103:3167–3182.PubMedCrossRef Thia KT, Loftus EV Jr., Sandborn WJ, Yang SK. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol. 2008;103:3167–3182.PubMedCrossRef
28.
Zurück zum Zitat Zheng JJ, Zhu XS, Huangfu Z, Gao ZX, Guo ZR, Wang Z. Crohn’s disease in mainland China: a systematic analysis of 50 years of research. Chin J Dig Dis. 2005;6:175–181.PubMedCrossRef Zheng JJ, Zhu XS, Huangfu Z, Gao ZX, Guo ZR, Wang Z. Crohn’s disease in mainland China: a systematic analysis of 50 years of research. Chin J Dig Dis. 2005;6:175–181.PubMedCrossRef
29.
Zurück zum Zitat Yao T, Matsui T, Hiwatashi N. Crohn’s disease in Japan: diagnostic criteria and epidemiology. Dis Colon Rectum. 2000;43:S85–S93.PubMedCrossRef Yao T, Matsui T, Hiwatashi N. Crohn’s disease in Japan: diagnostic criteria and epidemiology. Dis Colon Rectum. 2000;43:S85–S93.PubMedCrossRef
30.
Zurück zum Zitat Garcia Rodriguez LA, Ruigomez A, Panes J. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology. 2006;130:1588–1594.PubMedCrossRef Garcia Rodriguez LA, Ruigomez A, Panes J. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology. 2006;130:1588–1594.PubMedCrossRef
31.
Zurück zum Zitat Darfeuille-Michaud A, Boudeau J, Bulois P, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease. Gastroenterology. 2004;127:412–421.PubMedCrossRef Darfeuille-Michaud A, Boudeau J, Bulois P, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease. Gastroenterology. 2004;127:412–421.PubMedCrossRef
32.
Zurück zum Zitat Gradel KO, Nielsen HL, Schonheyder HC, Ejlertsen T, Kristensen B, Nielsen H. Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis. Gastroenterology. 2009;137:495–501.PubMedCrossRef Gradel KO, Nielsen HL, Schonheyder HC, Ejlertsen T, Kristensen B, Nielsen H. Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis. Gastroenterology. 2009;137:495–501.PubMedCrossRef
33.
Zurück zum Zitat Peeters H, Bogaert S, Laukens D, et al. CARD15 variants determine a disturbed early response of monocytes to adherent-invasive Escherichia coli strain LF82 in Crohn’s disease. Int J Immunogenet. 2007;34:181–191.PubMedCrossRef Peeters H, Bogaert S, Laukens D, et al. CARD15 variants determine a disturbed early response of monocytes to adherent-invasive Escherichia coli strain LF82 in Crohn’s disease. Int J Immunogenet. 2007;34:181–191.PubMedCrossRef
34.
Zurück zum Zitat Bernstein CN, Nayar G, Hamel A, Blanchard JF. Study of animal-borne infections in the mucosas of patients with inflammatory bowel disease and population-based controls. J Clin Microbiol. 2003;41:4986–4990.PubMedPubMedCentralCrossRef Bernstein CN, Nayar G, Hamel A, Blanchard JF. Study of animal-borne infections in the mucosas of patients with inflammatory bowel disease and population-based controls. J Clin Microbiol. 2003;41:4986–4990.PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Bernstein CN, Blanchard JF, Rawsthorne P, Collins MT. Population-based case control study of seroprevalence of Mycobacterium paratuberculosis in patients with Crohn’s disease and ulcerative colitis. J Clin Microbiol. 2004;42:1129–1135.PubMedPubMedCentralCrossRef Bernstein CN, Blanchard JF, Rawsthorne P, Collins MT. Population-based case control study of seroprevalence of Mycobacterium paratuberculosis in patients with Crohn’s disease and ulcerative colitis. J Clin Microbiol. 2004;42:1129–1135.PubMedPubMedCentralCrossRef
36.
Zurück zum Zitat Naser SA, Ghobrial G, Romero C, Valentine JF. Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn’s disease. Lancet. 2004;364:1039–1044.CrossRef Naser SA, Ghobrial G, Romero C, Valentine JF. Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn’s disease. Lancet. 2004;364:1039–1044.CrossRef
37.
Zurück zum Zitat Ryan P, Bennett MW, Aarons S, et al. PCR detection of Mycobacterium paratuberculosis in Crohn’s disease granulomas isolated by laser capture microdissection. Gut. 2002;51:665–670.PubMedPubMedCentralCrossRef Ryan P, Bennett MW, Aarons S, et al. PCR detection of Mycobacterium paratuberculosis in Crohn’s disease granulomas isolated by laser capture microdissection. Gut. 2002;51:665–670.PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Bull TJ, McMinn EJ, Sidi-Boumedine K, et al. Detection and verification of Mycobacterium avium subsp. paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn’s disease. J Clin Microbiol. 2003;41:2915–2923.PubMedPubMedCentralCrossRef Bull TJ, McMinn EJ, Sidi-Boumedine K, et al. Detection and verification of Mycobacterium avium subsp. paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn’s disease. J Clin Microbiol. 2003;41:2915–2923.PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat Feller M, Huwiler K, Stephan R, et al. Mycobacterium avium subspecies paratuberculosis and Crohn’s disease: a systematic review and meta-analysis. Lancet Infect Dis. 2007;7:607–613.PubMedCrossRef Feller M, Huwiler K, Stephan R, et al. Mycobacterium avium subspecies paratuberculosis and Crohn’s disease: a systematic review and meta-analysis. Lancet Infect Dis. 2007;7:607–613.PubMedCrossRef
40.
Zurück zum Zitat Selby W, Pavli P, Crotty B, et al. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn’s disease. Gastroenterology. 2007;132:2313–2319.PubMedCrossRef Selby W, Pavli P, Crotty B, et al. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn’s disease. Gastroenterology. 2007;132:2313–2319.PubMedCrossRef
42.
Zurück zum Zitat Korzenik JR. Past and current theories of etiology of IBD: toothpaste, worms, and refrigerators. J Clin Gastroenterol. 2005;39:S59–S65.PubMedCrossRef Korzenik JR. Past and current theories of etiology of IBD: toothpaste, worms, and refrigerators. J Clin Gastroenterol. 2005;39:S59–S65.PubMedCrossRef
43.
Zurück zum Zitat Standaert-Vitse A, Sendid B, Joossens M, et al. Candida albicans colonization and ASCA in familial Crohn’s disease. Am J Gastroenterol. 2009;104:1745–1753.PubMedCrossRef Standaert-Vitse A, Sendid B, Joossens M, et al. Candida albicans colonization and ASCA in familial Crohn’s disease. Am J Gastroenterol. 2009;104:1745–1753.PubMedCrossRef
44.
Zurück zum Zitat Kalkanci A, Tuncer C, Degertekin B, et al. Detection of Candida albicans by culture, serology and PCR in clinical specimens from patients with ulcerative colitis: re-evaluation of an old hypothesis with a new perspective. Folia Microbiol. 2005;50:263–267.CrossRef Kalkanci A, Tuncer C, Degertekin B, et al. Detection of Candida albicans by culture, serology and PCR in clinical specimens from patients with ulcerative colitis: re-evaluation of an old hypothesis with a new perspective. Folia Microbiol. 2005;50:263–267.CrossRef
45.
Zurück zum Zitat McKenzie H, Main J, Pennington CR, Parratt D. Antibody to selected strains of Saccharomyces cerevisiae (baker’s and brewer’s yeast) and Candida albicans in Crohn’s disease. Gut. 1990;31:536–538.PubMedPubMedCentralCrossRef McKenzie H, Main J, Pennington CR, Parratt D. Antibody to selected strains of Saccharomyces cerevisiae (baker’s and brewer’s yeast) and Candida albicans in Crohn’s disease. Gut. 1990;31:536–538.PubMedPubMedCentralCrossRef
46.
Zurück zum Zitat Bernstein CN, Kraut A, Blanchard JF, Rawsthorne P, Yu N, Walld R. The relationship between inflammatory bowel disease and socioeconomic variables. Am J Gastroenterol. 2001;96:2117–2125.PubMedCrossRef Bernstein CN, Kraut A, Blanchard JF, Rawsthorne P, Yu N, Walld R. The relationship between inflammatory bowel disease and socioeconomic variables. Am J Gastroenterol. 2001;96:2117–2125.PubMedCrossRef
47.
Zurück zum Zitat Cardenas VM, Mulla ZD, Ortiz M, Graham DY. Iron deficiency and Helicobacter pylori infection in the United States. Am J Epidemiol. 2006;163:127–134.PubMedCrossRef Cardenas VM, Mulla ZD, Ortiz M, Graham DY. Iron deficiency and Helicobacter pylori infection in the United States. Am J Epidemiol. 2006;163:127–134.PubMedCrossRef
48.
Zurück zum Zitat Everhart JE, Kruszon-Moran D, Perez-Perez GI, Tralka TS, McQuillan G. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infect Dis. 2000;181:1359–1363.PubMedCrossRef Everhart JE, Kruszon-Moran D, Perez-Perez GI, Tralka TS, McQuillan G. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infect Dis. 2000;181:1359–1363.PubMedCrossRef
49.
Zurück zum Zitat Lane JA, Murray LJ, Harvey IM, Donovan JL, Nair P, Harvey RF. Randomised clinical trial: Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study. Aliment Pharmacol Ther. 2011;33:922–929.PubMedCrossRef Lane JA, Murray LJ, Harvey IM, Donovan JL, Nair P, Harvey RF. Randomised clinical trial: Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study. Aliment Pharmacol Ther. 2011;33:922–929.PubMedCrossRef
50.
Zurück zum Zitat Gunesh S, Thomas GA, Williams GT, Roberts A, Hawthorne AB. The incidence of Crohn’s disease in Cardiff over the last 75 years: an update for 1996–2005. Aliment Pharmacol Ther. 2008;27:211–219.PubMedCrossRef Gunesh S, Thomas GA, Williams GT, Roberts A, Hawthorne AB. The incidence of Crohn’s disease in Cardiff over the last 75 years: an update for 1996–2005. Aliment Pharmacol Ther. 2008;27:211–219.PubMedCrossRef
51.
Zurück zum Zitat Martin-de-Argila C, Boixeda D, Canton R, et al. Helicobacter pylori infection in a healthy population in Spain. Eur J Gastroenterol Hepatol. 1996;8:1165–1168.PubMedCrossRef Martin-de-Argila C, Boixeda D, Canton R, et al. Helicobacter pylori infection in a healthy population in Spain. Eur J Gastroenterol Hepatol. 1996;8:1165–1168.PubMedCrossRef
52.
Zurück zum Zitat Garrido A, Martinez MJ, Ortega JA, Lobato A, Rodriguez MJ, Guerrero FJ. Epidemiology of chronic inflammatory bowel disease in the Northern area of Huelva. Rev Esp Enferm Dig. 2004;96:687–691. (91–94).PubMedCrossRef Garrido A, Martinez MJ, Ortega JA, Lobato A, Rodriguez MJ, Guerrero FJ. Epidemiology of chronic inflammatory bowel disease in the Northern area of Huelva. Rev Esp Enferm Dig. 2004;96:687–691. (91–94).PubMedCrossRef
53.
Zurück zum Zitat Sanchez Ceballos F, Taxonera Samso C, Garcia Alonso M, Alba Lopez C, Sainz de Los Terreros Soler L, Diaz-Rubio M. Prevalence of Helicobacter pylori infection in the healthy population of Madrid (Spain). Rev Esp Enferm Dig. 2007;99:497–501.PubMedCrossRef Sanchez Ceballos F, Taxonera Samso C, Garcia Alonso M, Alba Lopez C, Sainz de Los Terreros Soler L, Diaz-Rubio M. Prevalence of Helicobacter pylori infection in the healthy population of Madrid (Spain). Rev Esp Enferm Dig. 2007;99:497–501.PubMedCrossRef
54.
Zurück zum Zitat Lopez-Serrano P, Perez-Calle JL, Carrera-Alonso E, et al. Epidemiologic study on the current incidence of inflammatory bowel disease in Madrid. Rev Esp Enferm Dig. 2009;101:768–772.PubMedCrossRef Lopez-Serrano P, Perez-Calle JL, Carrera-Alonso E, et al. Epidemiologic study on the current incidence of inflammatory bowel disease in Madrid. Rev Esp Enferm Dig. 2009;101:768–772.PubMedCrossRef
55.
Zurück zum Zitat Macenlle Garcia R, Gayoso Diz P, Sueiro Benavides RA, Fernandez Seara J. Prevalence of Helicobacter pylori infection in the general adult population of the province of Ourense. Rev Esp Enferm Dig. 2006;98:241–248.PubMed Macenlle Garcia R, Gayoso Diz P, Sueiro Benavides RA, Fernandez Seara J. Prevalence of Helicobacter pylori infection in the general adult population of the province of Ourense. Rev Esp Enferm Dig. 2006;98:241–248.PubMed
56.
Zurück zum Zitat Arin Letamendia A, Burusco Paternain MJ, Borda Celaya F, Pueyo Royo A, Martinez Echeverria A, Jimenez Perez FJ. Epidemiological aspects of inflammatory bowel disease in the Pamplona area. Rev Esp Enferm Dig. 1999;91:769–776.PubMed Arin Letamendia A, Burusco Paternain MJ, Borda Celaya F, Pueyo Royo A, Martinez Echeverria A, Jimenez Perez FJ. Epidemiological aspects of inflammatory bowel disease in the Pamplona area. Rev Esp Enferm Dig. 1999;91:769–776.PubMed
57.
Zurück zum Zitat Senra-Varela A, Lopez-Saez JB, Gomez-Biondi V. Prevalence of Helicobacter pylori infection in two Spanish regions with different incidence of gastric cancer. Eur J Epidemiol. 1998;14:491–494.PubMedCrossRef Senra-Varela A, Lopez-Saez JB, Gomez-Biondi V. Prevalence of Helicobacter pylori infection in two Spanish regions with different incidence of gastric cancer. Eur J Epidemiol. 1998;14:491–494.PubMedCrossRef
58.
Zurück zum Zitat Monferrer Guardiola R, Martin Jimenez JA, Pedraza Sanz RG, Moreno Sanchez I, Soler Bahilo E, Hinojosa del Val J. Incidence of inflammatory bowel disease in the 02 health area of Castellon (1992–1996). Rev Esp Enferm Dig. 1999;91:33–46.PubMed Monferrer Guardiola R, Martin Jimenez JA, Pedraza Sanz RG, Moreno Sanchez I, Soler Bahilo E, Hinojosa del Val J. Incidence of inflammatory bowel disease in the 02 health area of Castellon (1992–1996). Rev Esp Enferm Dig. 1999;91:33–46.PubMed
59.
Zurück zum Zitat Rodrigo Saez L, Riestra Menendez S, Fernandez Rodriguez E, Fernandez Velazquez MR, Garcia Alonso S, Lauret Brana ME. Epidemiological study of the prevalence of Helicobacter pylori infection in the general population in Asturias. Spain Revista espanola de enfermedades digestivas. 1997;89:511–522.PubMed Rodrigo Saez L, Riestra Menendez S, Fernandez Rodriguez E, Fernandez Velazquez MR, Garcia Alonso S, Lauret Brana ME. Epidemiological study of the prevalence of Helicobacter pylori infection in the general population in Asturias. Spain Revista espanola de enfermedades digestivas. 1997;89:511–522.PubMed
60.
Zurück zum Zitat Pozzati L, Cabanillas A. Hospital study of the incidence of inflammatory bowel disease in the health district of Merida (Spain). Gastroenterol Hepatol. 2002;25:541–544.PubMedCrossRef Pozzati L, Cabanillas A. Hospital study of the incidence of inflammatory bowel disease in the health district of Merida (Spain). Gastroenterol Hepatol. 2002;25:541–544.PubMedCrossRef
61.
Zurück zum Zitat Nishise Y, Fukao A, Takahashi T. Risk factors for Helicobacter pylori infection among a rural population in Japan: relation to living environment and medical history. J Epidemiol. 2003;13:266–273.PubMedCrossRef Nishise Y, Fukao A, Takahashi T. Risk factors for Helicobacter pylori infection among a rural population in Japan: relation to living environment and medical history. J Epidemiol. 2003;13:266–273.PubMedCrossRef
62.
Zurück zum Zitat Morita N, Toki S, Hirohashi T, et al. Incidence and prevalence of inflammatory bowel disease in Japan: nationwide epidemiological survey during the year 1991. J Gastroenterol. 1995;30:1–4.PubMedCrossRef Morita N, Toki S, Hirohashi T, et al. Incidence and prevalence of inflammatory bowel disease in Japan: nationwide epidemiological survey during the year 1991. J Gastroenterol. 1995;30:1–4.PubMedCrossRef
63.
Zurück zum Zitat Asaka M, Kato M, Kudo M, et al. Relationship between Helicobacter pylori infection, atrophic gastritis and gastric carcinoma in a Japanese population. Eur J Gastroenterol Hepatol. 1995;7:S7–S10.PubMed Asaka M, Kato M, Kudo M, et al. Relationship between Helicobacter pylori infection, atrophic gastritis and gastric carcinoma in a Japanese population. Eur J Gastroenterol Hepatol. 1995;7:S7–S10.PubMed
64.
Zurück zum Zitat De Bastiani R, Gabrielli M, Ubaldi E, et al. High prevalence of Cag-A positive H. pylori strains in ischemic stroke: a primary care multicenter study. Helicobacter. 2008;13:274–277.PubMedCrossRef De Bastiani R, Gabrielli M, Ubaldi E, et al. High prevalence of Cag-A positive H. pylori strains in ischemic stroke: a primary care multicenter study. Helicobacter. 2008;13:274–277.PubMedCrossRef
65.
Zurück zum Zitat Dal Pont E, Lecis P, Galliani EA, Cavallaro LG, et al. Inflammatory bowel disease (IBD) incidence and prevalence in a north eat limited area of Italy. Dig Liver Dis. 2010;42S:S61–S192. Dal Pont E, Lecis P, Galliani EA, Cavallaro LG, et al. Inflammatory bowel disease (IBD) incidence and prevalence in a north eat limited area of Italy. Dig Liver Dis. 2010;42S:S61–S192.
66.
Zurück zum Zitat Russo A, Eboli M, Pizzetti P, et al. Determinants of Helicobacter pylori seroprevalence among Italian blood donors. Eur J Gastroenterol Hepatol. 1999;11:867–873.PubMedCrossRef Russo A, Eboli M, Pizzetti P, et al. Determinants of Helicobacter pylori seroprevalence among Italian blood donors. Eur J Gastroenterol Hepatol. 1999;11:867–873.PubMedCrossRef
67.
Zurück zum Zitat Tragnone A, Corrao G, Miglio F, Caprilli R, Lanfranchi GA. Incidence of inflammatory bowel disease in Italy: a nationwide population-based study. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Int J Epidemiol. 1996;25:1044–1052.PubMedCrossRef Tragnone A, Corrao G, Miglio F, Caprilli R, Lanfranchi GA. Incidence of inflammatory bowel disease in Italy: a nationwide population-based study. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Int J Epidemiol. 1996;25:1044–1052.PubMedCrossRef
68.
Zurück zum Zitat Iszlai E, Kiss E, Toldy E, et al. Seroprevalence of Helicobacter pylori infection and anti-CagA positivity in the county Szabolcs–Szatmar–Bereg. Orv Hetil. 2003;144:1713–1718.PubMed Iszlai E, Kiss E, Toldy E, et al. Seroprevalence of Helicobacter pylori infection and anti-CagA positivity in the county Szabolcs–Szatmar–Bereg. Orv Hetil. 2003;144:1713–1718.PubMed
69.
Zurück zum Zitat Lakatos L, Mester G, Erdelyi Z, et al. [Epidemiology of inflammatory bowel diseases in Veszprem county of Western Hungary between 1977 and 2001]. Orv Hetil. 2001;144:1819–1827. Lakatos L, Mester G, Erdelyi Z, et al. [Epidemiology of inflammatory bowel diseases in Veszprem county of Western Hungary between 1977 and 2001]. Orv Hetil. 2001;144:1819–1827.
70.
Zurück zum Zitat Stettin D, Waldmann A, Wolters M, Trunz B. Schauder P and Hahn A 2007 Infection with Helicobacter pylori–outcome of a cross-sectional investigation. Dtsch Med Wochenschr. 1946;132:2677–2682.CrossRef Stettin D, Waldmann A, Wolters M, Trunz B. Schauder P and Hahn A 2007 Infection with Helicobacter pylori–outcome of a cross-sectional investigation. Dtsch Med Wochenschr. 1946;132:2677–2682.CrossRef
71.
Zurück zum Zitat Ott C, Obermeier F, Thieler S, et al. The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study. Eur J Gastroenterol Hepatol. 2008;20:917–923.PubMedCrossRef Ott C, Obermeier F, Thieler S, et al. The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study. Eur J Gastroenterol Hepatol. 2008;20:917–923.PubMedCrossRef
72.
Zurück zum Zitat Holtmann G, Goebell H, Holtmann M, Talley NJ. Dyspepsia in healthy blood donors. Pattern of symptoms and association with Helicobacter pylori. Dig Dis Sci. 1994;39:1090–1098.PubMedCrossRef Holtmann G, Goebell H, Holtmann M, Talley NJ. Dyspepsia in healthy blood donors. Pattern of symptoms and association with Helicobacter pylori. Dig Dis Sci. 1994;39:1090–1098.PubMedCrossRef
73.
Zurück zum Zitat Timmer A, Breuer-Katschinski B, Goebell H. Time trends in the incidence and disease location of Crohn’s disease 1980–1995: a prospective analysis in an urban population in Germany. Inflamm Bowel Dis. 1999;5:79–84.PubMedCrossRef Timmer A, Breuer-Katschinski B, Goebell H. Time trends in the incidence and disease location of Crohn’s disease 1980–1995: a prospective analysis in an urban population in Germany. Inflamm Bowel Dis. 1999;5:79–84.PubMedCrossRef
74.
Zurück zum Zitat Salomaa-Rasanen A, Kosunen TU, Aromaa AR, Knekt P, Sarna S, Rautelin H. A “screen-and-treat” approach for Helicobacter pylori infection: a population-based study in Vammala, Finland. Helicobacter. 2010;15:28–37.PubMedCrossRef Salomaa-Rasanen A, Kosunen TU, Aromaa AR, Knekt P, Sarna S, Rautelin H. A “screen-and-treat” approach for Helicobacter pylori infection: a population-based study in Vammala, Finland. Helicobacter. 2010;15:28–37.PubMedCrossRef
75.
Zurück zum Zitat Manninen P, Karvonen AL, Huhtala H, Rasmussen M, Collin P. The epidemiology of inflammatory bowel diseases in Finland. Scand J Gastroenterol. 2010;45:1063–1067.PubMedCrossRef Manninen P, Karvonen AL, Huhtala H, Rasmussen M, Collin P. The epidemiology of inflammatory bowel diseases in Finland. Scand J Gastroenterol. 2010;45:1063–1067.PubMedCrossRef
76.
Zurück zum Zitat Moayyedi P, Axon AT, Feltbower R, et al. Relation of adult lifestyle and socioeconomic factors to the prevalence of Helicobacter pylori infection. Int J Epidemiol. 2002;31:624–631.PubMedCrossRef Moayyedi P, Axon AT, Feltbower R, et al. Relation of adult lifestyle and socioeconomic factors to the prevalence of Helicobacter pylori infection. Int J Epidemiol. 2002;31:624–631.PubMedCrossRef
77.
Zurück zum Zitat Rubin GP, Hungin AP, Kelly PJ, Ling J. Inflammatory bowel disease: epidemiology and management in an English general practice population. Aliment Pharmacol Ther. 2000;14:1553–1559.PubMedCrossRef Rubin GP, Hungin AP, Kelly PJ, Ling J. Inflammatory bowel disease: epidemiology and management in an English general practice population. Aliment Pharmacol Ther. 2000;14:1553–1559.PubMedCrossRef
78.
Zurück zum Zitat Rosenstock S, Jorgensen T, Andersen L, Bonnevie O. Seroconversion and seroreversion in IgG antibodies to Helicobacter pylori: a serology based prospective cohort study. J Epidemiol Community Health. 2000;54:444–450.PubMedPubMedCentralCrossRef Rosenstock S, Jorgensen T, Andersen L, Bonnevie O. Seroconversion and seroreversion in IgG antibodies to Helicobacter pylori: a serology based prospective cohort study. J Epidemiol Community Health. 2000;54:444–450.PubMedPubMedCentralCrossRef
79.
Zurück zum Zitat Munkholm P, Langholz E, Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of Crohn’s disease in the county of Copenhagen, 1962–87: a sixfold increase in incidence. Scand J Gastroenterol. 1992;27:609–614.PubMedCrossRef Munkholm P, Langholz E, Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of Crohn’s disease in the county of Copenhagen, 1962–87: a sixfold increase in incidence. Scand J Gastroenterol. 1992;27:609–614.PubMedCrossRef
80.
Zurück zum Zitat Munkholm P, Langholz E, Nielsen OH, Kreiner S, Binder V. Increased incidence of Crohn disease in the county of Copenhagen. Ugeskr Laeger. 1993;155:3199–3202.PubMed Munkholm P, Langholz E, Nielsen OH, Kreiner S, Binder V. Increased incidence of Crohn disease in the county of Copenhagen. Ugeskr Laeger. 1993;155:3199–3202.PubMed
81.
Zurück zum Zitat Babus V, Presecki V, Katicic M, et al. Distribution of Helicobacter pylori infection in the adult population of Croatia. Lijec Vjesn. 1997;119:139–142.PubMed Babus V, Presecki V, Katicic M, et al. Distribution of Helicobacter pylori infection in the adult population of Croatia. Lijec Vjesn. 1997;119:139–142.PubMed
82.
Zurück zum Zitat Sincic BM, Vucelic B, Persic M, et al. Incidence of inflammatory bowel disease in Primorsko-goranska County, Croatia, 2000–2004: a prospective population-based study. Scand J Gastroenterol. 2006;41:437–444.PubMedCrossRef Sincic BM, Vucelic B, Persic M, et al. Incidence of inflammatory bowel disease in Primorsko-goranska County, Croatia, 2000–2004: a prospective population-based study. Scand J Gastroenterol. 2006;41:437–444.PubMedCrossRef
83.
84.
Zurück zum Zitat Lowe AM, Roy PO, Poulin MB, et al. Epidemiology of Crohn’s disease in Quebec, Canada. Inflamm Bowel Dis. 2009;15:429–435.PubMedCrossRef Lowe AM, Roy PO, Poulin MB, et al. Epidemiology of Crohn’s disease in Quebec, Canada. Inflamm Bowel Dis. 2009;15:429–435.PubMedCrossRef
85.
Zurück zum Zitat Veldhuyzen van Zanten SJ, Pollak PT, Best LM, Bezanson GS, Marrie T. Increasing prevalence of Helicobacter pylori infection with age: continuous risk of infection in adults rather than cohort effect. J Infect Dis. 1994;169:434–437.PubMedCrossRef Veldhuyzen van Zanten SJ, Pollak PT, Best LM, Bezanson GS, Marrie T. Increasing prevalence of Helicobacter pylori infection with age: continuous risk of infection in adults rather than cohort effect. J Infect Dis. 1994;169:434–437.PubMedCrossRef
86.
Zurück zum Zitat Green C, Elliott L, Beaudoin C, Bernstein CN. A population-based ecologic study of inflammatory bowel disease: searching for etiologic clues. Am J Epidemiol. 2006;164:615–623. (discussion 24–28).PubMedCrossRef Green C, Elliott L, Beaudoin C, Bernstein CN. A population-based ecologic study of inflammatory bowel disease: searching for etiologic clues. Am J Epidemiol. 2006;164:615–623. (discussion 24–28).PubMedCrossRef
87.
Zurück zum Zitat Whiteman DC, Parmar P, Fahey P, et al. Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers. Gastroenterology. 2010;139:73–83. (quiz e11–e12).PubMedCrossRef Whiteman DC, Parmar P, Fahey P, et al. Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers. Gastroenterology. 2010;139:73–83. (quiz e11–e12).PubMedCrossRef
88.
Zurück zum Zitat Anseline PF. Crohn’s disease in the Hunter Valley region of Australia. Aust N Z J Surg. 1995;65:564–569.PubMedCrossRef Anseline PF. Crohn’s disease in the Hunter Valley region of Australia. Aust N Z J Surg. 1995;65:564–569.PubMedCrossRef
89.
Zurück zum Zitat Iantorno G, Cinquetti M, Mazzocchi A, Morelli A, Bassotti G. Audit of constipation in a gastroenterology referral center. Dig Dis Sci. 2007;52:317–320.PubMedCrossRef Iantorno G, Cinquetti M, Mazzocchi A, Morelli A, Bassotti G. Audit of constipation in a gastroenterology referral center. Dig Dis Sci. 2007;52:317–320.PubMedCrossRef
90.
Zurück zum Zitat Kappelman MD, Rifas-Shiman SL, Kleinman K, et al. The prevalence and geographic distribution of Crohn’s disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007;5:1424–1429.PubMedCrossRef Kappelman MD, Rifas-Shiman SL, Kleinman K, et al. The prevalence and geographic distribution of Crohn’s disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007;5:1424–1429.PubMedCrossRef
91.
Zurück zum Zitat Graham DY, Malaty HM, Evans DG, Evans DJ Jr., Klein PD, Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology. 1991;100:1495–1501.PubMedCrossRef Graham DY, Malaty HM, Evans DG, Evans DJ Jr., Klein PD, Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology. 1991;100:1495–1501.PubMedCrossRef
92.
Zurück zum Zitat Loftus EV Jr., Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Crohn’s disease in Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and survival. Gastroenterology. 1998;114:1161–1168.PubMedCrossRef Loftus EV Jr., Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Crohn’s disease in Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and survival. Gastroenterology. 1998;114:1161–1168.PubMedCrossRef
93.
Zurück zum Zitat Stone MA, Mayberry JF, Baker R. Prevalence and management of inflammatory bowel disease: a cross-sectional study from central England. Eur J Gastroenterol Hepatol. 2003;15:1275–1280.PubMedCrossRef Stone MA, Mayberry JF, Baker R. Prevalence and management of inflammatory bowel disease: a cross-sectional study from central England. Eur J Gastroenterol Hepatol. 2003;15:1275–1280.PubMedCrossRef
94.
Zurück zum Zitat Saro Gismera C, Lacort Fernandez M, Arguelles Fernandez G, et al. Incidence and prevalence of inflammatory bowel disease in Gijon, Asturias, Spain. Gastroenterol Hepatol. 2000;23:322–327.PubMed Saro Gismera C, Lacort Fernandez M, Arguelles Fernandez G, et al. Incidence and prevalence of inflammatory bowel disease in Gijon, Asturias, Spain. Gastroenterol Hepatol. 2000;23:322–327.PubMed
95.
Zurück zum Zitat Saro Gismera C, Riestra Menendez S, Milla Crespo A, et al. Incidence and prevalence of inflammatory bowel disease. Asturian study in 5 areas (EIICEA), Spain. Anales de medicina interna. 2003;20:3–9.PubMed Saro Gismera C, Riestra Menendez S, Milla Crespo A, et al. Incidence and prevalence of inflammatory bowel disease. Asturian study in 5 areas (EIICEA), Spain. Anales de medicina interna. 2003;20:3–9.PubMed
96.
Zurück zum Zitat Peleteiro B, Lopes C, Figueiredo C, Lunet N. Salt intake and gastric cancer risk according to Helicobacter pylori infection, smoking, tumour site and histological type. Br J Cancer. 2011;104:198–207.PubMedCrossRef Peleteiro B, Lopes C, Figueiredo C, Lunet N. Salt intake and gastric cancer risk according to Helicobacter pylori infection, smoking, tumour site and histological type. Br J Cancer. 2011;104:198–207.PubMedCrossRef
97.
Zurück zum Zitat Azevedo LF, Magro F, Portela F, et al. Estimating the prevalence of inflammatory bowel disease in Portugal using a pharmaco-epidemiological approach. Pharmacoepidemiol Drug Saf. 2010;19:499–510.PubMed Azevedo LF, Magro F, Portela F, et al. Estimating the prevalence of inflammatory bowel disease in Portugal using a pharmaco-epidemiological approach. Pharmacoepidemiol Drug Saf. 2010;19:499–510.PubMed
98.
Zurück zum Zitat Asakura K, Nishiwaki Y, Inoue N, Hibi T, Watanabe M, Takebayashi T. Prevalence of ulcerative colitis and Crohn’s disease in Japan. J Gastroenterol. 2009;44:659–665.PubMedCrossRef Asakura K, Nishiwaki Y, Inoue N, Hibi T, Watanabe M, Takebayashi T. Prevalence of ulcerative colitis and Crohn’s disease in Japan. J Gastroenterol. 2009;44:659–665.PubMedCrossRef
99.
Zurück zum Zitat Bazzoli F, Palli D, Zagari RM, et al. The Loiano-Monghidoro population-based study of Helicobacter pylori infection: prevalence by 13C-urea breath test and associated factors. Aliment Pharmacol Ther. 2001;15:1001–1007.PubMedCrossRef Bazzoli F, Palli D, Zagari RM, et al. The Loiano-Monghidoro population-based study of Helicobacter pylori infection: prevalence by 13C-urea breath test and associated factors. Aliment Pharmacol Ther. 2001;15:1001–1007.PubMedCrossRef
100.
Zurück zum Zitat Trallori G, Palli D, Saieva C, et al. A population-based study of inflammatory bowel disease in Florence over 15 years (1978–92). Scand J Gastroenterol. 1996;31:892–899.PubMedCrossRef Trallori G, Palli D, Saieva C, et al. A population-based study of inflammatory bowel disease in Florence over 15 years (1978–92). Scand J Gastroenterol. 1996;31:892–899.PubMedCrossRef
101.
Zurück zum Zitat Breuer T, Sudhop T, Hoch J, Sauerbruch T, Malfertheiner P. Prevalence of and risk factors for Helicobacter pylori infection in the western part of Germany. Eur J Gastroenterol Hepatol. 1996;8:47–52.PubMedCrossRef Breuer T, Sudhop T, Hoch J, Sauerbruch T, Malfertheiner P. Prevalence of and risk factors for Helicobacter pylori infection in the western part of Germany. Eur J Gastroenterol Hepatol. 1996;8:47–52.PubMedCrossRef
102.
Zurück zum Zitat Loffler A, Glados M. Data on the epidemiology of Crohn disease in the city of Cologne. Med Klin. 1993;88:516–519. Loffler A, Glados M. Data on the epidemiology of Crohn disease in the city of Cologne. Med Klin. 1993;88:516–519.
103.
Zurück zum Zitat Dirks E, Forster S, Thom M, Quebe-Fehling E, Goebell H. Prospective study of the incidence and prevalence of ulcerative colitis in a large urban population in Germany (western Ruhr area). Z Gastroenterol. 1994;32:332–337.PubMed Dirks E, Forster S, Thom M, Quebe-Fehling E, Goebell H. Prospective study of the incidence and prevalence of ulcerative colitis in a large urban population in Germany (western Ruhr area). Z Gastroenterol. 1994;32:332–337.PubMed
104.
Zurück zum Zitat Jovanovic Z. Epidemiology of Crohn’s disease in the Rijeka–Istra region. Lijec Vjesn. 1999;121:8–13.PubMed Jovanovic Z. Epidemiology of Crohn’s disease in the Rijeka–Istra region. Lijec Vjesn. 1999;121:8–13.PubMed
Metadaten
Titel
Is There a Link Between H. Pylori and the Epidemiology of Crohn’s Disease?
verfasst von
Ayesha Shah
Nicholas J. Talley
Marjorie Walker
Natasha Koloski
Mark Morrison
Daniel Burger
Jane M. Andrews
Michael McGuckin
Mike Jones
Gerald Holtmann
Publikationsdatum
09.03.2017
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 9/2017
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-017-4496-z

Weitere Artikel der Ausgabe 9/2017

Digestive Diseases and Sciences 9/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.